Oligodendroglial hamartoma: A potential source of misdiagnosis for oligodendroglioma

Gianluca Marucci, Marco Giulioni, Matteo Martinoni, Lilia Volpi, Roberto Michelucci

Research output: Contribution to journalArticle

Abstract

Various subtypes of intracerebral hamartomas, associated with seizure disorders, have long been described. We describe a cerebral hamartoma placed in the left frontal lobe, associated with drug-resistant epilepsy, composed exclusively of mature oligodendroglial cells. The patient was a 27-year-old right-handed male presenting with severe epileptic encephalopathy and symptoms of behavior dysfunction (disinhibition, rage attacks) associated with a left frontal lesion. Magnetic resonance imaging revealed a small area iso-hypointense compared to the gray matter in T1-weighted sequences not enhancing after gadolinium contrast injection in the left frontal site. On histology, a cortical lesion composed of large aggregates of oligodendroglial cells, with round central nuclei and clear perinuclear halos, was observed. Neither mitotic figures nor necrosis were present. Reactivity for Ki67 and P53 was not found. The lesion was well demarcated from the adjacent brain parenchyma and perineuronal satellitosis was not observed in the cortex. In conclusion, albeit extremely rare, recognition of oligodendroglial hamartoma and its distinction from other epileptogenic lesions as dysembryoplastic neuroepithelial tumor or above all oligodendroglioma have important therapeutic and prognostic implications.

Original languageEnglish
Pages (from-to)325-328
Number of pages4
JournalJournal of Neuro-Oncology
Volume101
Issue number2
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Oligodendroglioma
Hamartoma
Diagnostic Errors
Neuroepithelial Neoplasms
Rage
Gadolinium
Brain Diseases
Frontal Lobe
Epilepsy
Histology
Necrosis
Magnetic Resonance Imaging
Injections
Brain
Therapeutics

Keywords

  • Dysembryoplastic neuroepithelial tumor
  • Epilepsy
  • Epilepsy surgery
  • Oligodendroglial hamartoma
  • Oligodendroglioma

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Oligodendroglial hamartoma : A potential source of misdiagnosis for oligodendroglioma. / Marucci, Gianluca; Giulioni, Marco; Martinoni, Matteo; Volpi, Lilia; Michelucci, Roberto.

In: Journal of Neuro-Oncology, Vol. 101, No. 2, 01.2011, p. 325-328.

Research output: Contribution to journalArticle

@article{f24084e7bea54064a90eb32b904acef2,
title = "Oligodendroglial hamartoma: A potential source of misdiagnosis for oligodendroglioma",
abstract = "Various subtypes of intracerebral hamartomas, associated with seizure disorders, have long been described. We describe a cerebral hamartoma placed in the left frontal lobe, associated with drug-resistant epilepsy, composed exclusively of mature oligodendroglial cells. The patient was a 27-year-old right-handed male presenting with severe epileptic encephalopathy and symptoms of behavior dysfunction (disinhibition, rage attacks) associated with a left frontal lesion. Magnetic resonance imaging revealed a small area iso-hypointense compared to the gray matter in T1-weighted sequences not enhancing after gadolinium contrast injection in the left frontal site. On histology, a cortical lesion composed of large aggregates of oligodendroglial cells, with round central nuclei and clear perinuclear halos, was observed. Neither mitotic figures nor necrosis were present. Reactivity for Ki67 and P53 was not found. The lesion was well demarcated from the adjacent brain parenchyma and perineuronal satellitosis was not observed in the cortex. In conclusion, albeit extremely rare, recognition of oligodendroglial hamartoma and its distinction from other epileptogenic lesions as dysembryoplastic neuroepithelial tumor or above all oligodendroglioma have important therapeutic and prognostic implications.",
keywords = "Dysembryoplastic neuroepithelial tumor, Epilepsy, Epilepsy surgery, Oligodendroglial hamartoma, Oligodendroglioma",
author = "Gianluca Marucci and Marco Giulioni and Matteo Martinoni and Lilia Volpi and Roberto Michelucci",
year = "2011",
month = "1",
doi = "10.1007/s11060-010-0253-2",
language = "English",
volume = "101",
pages = "325--328",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "2",

}

TY - JOUR

T1 - Oligodendroglial hamartoma

T2 - A potential source of misdiagnosis for oligodendroglioma

AU - Marucci, Gianluca

AU - Giulioni, Marco

AU - Martinoni, Matteo

AU - Volpi, Lilia

AU - Michelucci, Roberto

PY - 2011/1

Y1 - 2011/1

N2 - Various subtypes of intracerebral hamartomas, associated with seizure disorders, have long been described. We describe a cerebral hamartoma placed in the left frontal lobe, associated with drug-resistant epilepsy, composed exclusively of mature oligodendroglial cells. The patient was a 27-year-old right-handed male presenting with severe epileptic encephalopathy and symptoms of behavior dysfunction (disinhibition, rage attacks) associated with a left frontal lesion. Magnetic resonance imaging revealed a small area iso-hypointense compared to the gray matter in T1-weighted sequences not enhancing after gadolinium contrast injection in the left frontal site. On histology, a cortical lesion composed of large aggregates of oligodendroglial cells, with round central nuclei and clear perinuclear halos, was observed. Neither mitotic figures nor necrosis were present. Reactivity for Ki67 and P53 was not found. The lesion was well demarcated from the adjacent brain parenchyma and perineuronal satellitosis was not observed in the cortex. In conclusion, albeit extremely rare, recognition of oligodendroglial hamartoma and its distinction from other epileptogenic lesions as dysembryoplastic neuroepithelial tumor or above all oligodendroglioma have important therapeutic and prognostic implications.

AB - Various subtypes of intracerebral hamartomas, associated with seizure disorders, have long been described. We describe a cerebral hamartoma placed in the left frontal lobe, associated with drug-resistant epilepsy, composed exclusively of mature oligodendroglial cells. The patient was a 27-year-old right-handed male presenting with severe epileptic encephalopathy and symptoms of behavior dysfunction (disinhibition, rage attacks) associated with a left frontal lesion. Magnetic resonance imaging revealed a small area iso-hypointense compared to the gray matter in T1-weighted sequences not enhancing after gadolinium contrast injection in the left frontal site. On histology, a cortical lesion composed of large aggregates of oligodendroglial cells, with round central nuclei and clear perinuclear halos, was observed. Neither mitotic figures nor necrosis were present. Reactivity for Ki67 and P53 was not found. The lesion was well demarcated from the adjacent brain parenchyma and perineuronal satellitosis was not observed in the cortex. In conclusion, albeit extremely rare, recognition of oligodendroglial hamartoma and its distinction from other epileptogenic lesions as dysembryoplastic neuroepithelial tumor or above all oligodendroglioma have important therapeutic and prognostic implications.

KW - Dysembryoplastic neuroepithelial tumor

KW - Epilepsy

KW - Epilepsy surgery

KW - Oligodendroglial hamartoma

KW - Oligodendroglioma

UR - http://www.scopus.com/inward/record.url?scp=78651320422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651320422&partnerID=8YFLogxK

U2 - 10.1007/s11060-010-0253-2

DO - 10.1007/s11060-010-0253-2

M3 - Article

C2 - 20532810

AN - SCOPUS:78651320422

VL - 101

SP - 325

EP - 328

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -